ARCT FY 2020 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena

ARCTArcturus Therapeutics Holdings Inc.

$210M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M-54.1% YoY

Gross Profit

-$46M-486.5% margin

Operating Income

-$72M-749.8% margin

Net Income

-$72M-756.3% margin

EPS (Diluted)

$-3.55

Cash Flow

Operating Cash Flow

-$43M

Free Cash Flow

-$45M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$476M

Total Liabilities

$80M

Stockholders' Equity

$397M

Cash & Equivalents

$463M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$21M	-54.1%
Gross Profit	-$46M	$21M	-323.2%
Operating Income	-$72M	-$26M	-180.3%
Net Income	-$72M	-$26M	-177.6%